Caxton Associates (New York)’s Steris STE Stock Holding History

Caxton Associates (New York)’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,544	Closed	-$1.42M	–	599
2022 Q3	$1.42M	Buy	+8,544	New	+$1.74M	0.19%	55
2019 Q3	–	Sell	-3,959	Closed	-$589K	–	535
2019 Q2	$589K	Sell	3,959 -4,736	-54%	-$633K	0.07%	167
2019 Q1	$1.11M	Buy	+8,695	New	+$1.02M	0.16%	68
2018 Q4	–	Sell	-7,743	Closed	-$886K	–	457
2018 Q3	$886K	Buy	7,743 +4,108	+113%	+$465K	0.06%	157
2018 Q2	$382K	Buy	+3,635	New	+$366K	0.02%	281

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Associates (New York)'s STE Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Steris (STE) in Q4 2022, closing a stake of 8,544 shares — an estimated $1.42M sold.

Caxton Associates (New York) first reported a position in STE in Q2 2018 and held it in 5 quarters. The position peaked at $1.42M in Q3 2022. 647 funds tracked by Wall St. Rank hold STE as of Q4 2022.

Caxton Associates (New York) reported no remaining Steris position as of Q4 2022 after selling out during the quarter.
Caxton Associates (New York) sold 8,544 Steris shares in Q4 2022, an estimated $1.42M.
Caxton Associates (New York) first reported a position in Steris in Q2 2018 and held it in 5 quarters.
Caxton Associates (New York)'s Steris position peaked at $1.42M in Q3 2022.
647 funds tracked by Wall St. Rank held Steris as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.